Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1498 (LINC01498) is a member of the lincRNA subclass, characterized as autonomously transcribed long non-coding RNAs longer than 200 nucleotides that do not overlap protein-coding genes[1][5]. LINC01498 is non-protein coding and is presumed to play roles in chromatin remodeling, epigenetic regulation, and possibly the fine-tuning of neighboring gene expression, similar to other lincRNAs[5]. As with most lincRNAs, specific molecular functions and disease implications of LINC01498 remain largely uncharacterized in current public scientific literature[1][5]. It is not established as a therapeutic target, and there are no known drug interactions or biomarker roles currently associated with LINC01498.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1498 (LINC01498).